acquired
Stage
About
Kymab develops human monoclonal antibody therapeutics for the treatment of various diseases, utilizing a proprietary antibody discovery platform.
Explore Kymab's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.